Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 23,745 shares at $1.74 ($42K) on 2017-12-07, disclosed to the SEC on 2017-12-08.
Open-market purchase of $42k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 16,106 | $29K | 68.6% |
| 2 | $1.74 | 7,639 | $13K | 31.4% |
| Total | $1.78 avg | 23,745 | $42K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |